In plain terms — abrdn Healthcare Investors
Shares currently cost about 6.3% less than the value of the assets behind them (a discount).
Over the past year it has averaged a 7.1% discount, so today's level is not high for this fund (Z-score +0.0). That describes the past; it does not predict where the discount goes next.
It pays regular distributions worth about 13.7% a year of the share price (12.8% of the assets). That is a payout rate, not a return: part of it may be capital being handed back.
Because the shares trade below the value of their assets, each dollar of reinvested distributions buys about $1.07 of assets — a ReinvestCapture™ rate of 14.6%, more than the payout rate itself. That is buying power, not a return.
The assets themselves grew 12.3% over the past year including distributions (NAV total return).
Guided view hides the statistical panels. Switch to Expert view in the grey bar to see them. Nothing here is advice.
Price and NAV, past year
Snapshot
Valuation vs. history
| Window | Average prem/disc | Std. dev. | Z-score | Observations |
|---|---|---|---|---|
| 3 months | -5.50% | 2.37% | -0.69 | 55 |
| 6 months | -5.78% | 2.12% | -0.64 | 106 |
| 1 year | -7.14% | 2.42% | +0.00 | 207 |
| 3 years | -9.91% | — | — | — |
| 5 years | -9.20% | — | — | — |
Current contemporaneous premium/discount -7.14% (close Oct 14, 2026 vs NAV Oct 13, 2026). 1-year range -11.63% to -2.03%. A negative Z-score means a wider discount than the window average — not that the fund is undervalued.
Performance
| Series | 1M | 3M | YTD | 1Y | 3Y (ann.) | 5Y (ann.) |
|---|---|---|---|---|---|---|
| Market price return | -13.24% | -9.36% | +0.69% | +0.90% | +7.28% | -5.92% |
| Market price total return | -13.24% | -6.81% | +10.15% | +13.79% | +21.38% | +5.01% |
| NAV return | -9.49% | -12.30% | -0.58% | +0.24% | +3.04% | -3.82% |
| NAV total return | -9.49% | -9.90% | +8.43% | +12.26% | +15.34% | +6.36% |
Through Oct 14, 2026. Total return reinvests distributions at the series value on the ex-date. Cumulative ≤ 1 year, annualised beyond.
About the fund
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
CEF Explorer research page for abrdn Healthcare Investors. Figures carry their own dates and sources; a discount to NAV does not guarantee convergence or any return. This is not investment advice.